Iron Oxide Nanoparticles in Cancer Treatment: Cell Responses and the Potency to Improve Radiosensitivity
Pharmaceutics · 30.09.2023 · 15 (10) · 2406
DOI: 10.3390/pharmaceutics15102406 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 30.09.2023. Verfasst von Maria V Shestovskaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agenc…. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The main concept of radiosensitization is making the tumor tissue more responsive to ionizing radiation, which leads to an increase in the potency of radiation therapy and allows for decreasing radiation dose and the concomitant side effects. Radiosensitization by metal oxide nanoparticles is widely discussed, but the range of mechanisms studied is not sufficiently codified and often does not reflect the ability of nanocarriers to have a specific impact on cells. This review is focused on the magnetic iron oxide nanoparticles while they occupied a special niche among the prospective radiosensitizers due to unique physicochemical characteristics and reactivity. We collected data about the possible molecular mechanisms underlying the radiosensitizing effects of iron oxide nanoparticles (IONPs) and the main approaches to increase their therapeutic efficacy by variable modifications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Schukinskaya st. 5/1, Moscow 119435, Russia.
- The Department of Technology of Chemical, Pharmaceutical and Cosmetic Products Mendeleev of University of Chemical Technology of Russia, Miusskaya sq. 9, Moscow 125047, Russia.
- P. Hertsen Moscow Oncology Research Institute of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinskiy p. 3, Moscow 125284, Russia.
ORCID-Profile: Maria V Shestovskaya, Anna L Luss, Olga A Bezborodova
Zitieren
APA
Shestovskaya, M. V., Luss, A. L., Bezborodova, O. A., Makarov, V. V., & Keskinov, A. A. (2023). Iron Oxide Nanoparticles in Cancer Treatment: Cell Responses and the Potency to Improve Radiosensitivity. Pharmaceutics, 15(10), 2406. https://doi.org/10.3390/pharmaceutics15102406
Vancouver
Shestovskaya MV, Luss AL, Bezborodova OA, Makarov VV, Keskinov AA. Iron Oxide Nanoparticles in Cancer Treatment: Cell Responses and the Potency to Improve Radiosensitivity. Pharmaceutics. 2023;15(10):2406. doi:10.3390/pharmaceutics15102406
BibTeX
@article{Shestovskaya2023,
author = {Shestovskaya, Maria V and Luss, Anna L and Bezborodova, Olga A and Makarov, Valentin V and Keskinov, Anton A},
title = {Iron Oxide Nanoparticles in Cancer Treatment: Cell Responses and the Potency to Improve Radiosensitivity},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {10},
pages = {2406},
doi = {10.3390/pharmaceutics15102406}
}
EUVIMED